Clinical studies indicate that participants can lose an average of 15 to 20 percent of their body weight over 72 weeks
GLP-1 receptor agonists, such as Wegovy, which contain the active ingredient semaglutide, are a class of medications widely used for obesity and type 2 diabetes
Call us at (206) 324-1120 to schedule a free consultation with one of our expert providers today.
The FDA warns that women on tirzepatide should use backup birth control methods, especially: During the first 4 weeks of starting the medication For 4 weeks after each dose increase Better Birth Control Options Choose methods that dont rely on absorption through your stomach: IUD (intrauterine device) Birth control implant Birth control shot Condoms and other barrier methods These options work independently of your digestive system
Another important component of the treatment with GLP-1RA is the inclusion of lifestyle interventions, including exercise and a low-calorie diet (1, 59)
Cited Sources & Resources The References section for this guide was compiled using data from high-authority sources, including peer-reviewed clinical validation studies on Retatrutide Peptide, research published in reputable scientific journals, doctoral dissertations and university studies, and clinical reviews